SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Hubert H. Humphrey

PatientHubert H. Humphrey
Date of birth1960-05-27
IdentifiersMRN HR-ML022-SYN; SSN (made up) 000-22-8047
Document date2026-07-07
AuthorWalter Brandvold, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Nine-month follow-up after cystectomy; acid-base on sodium bicarbonate. [S]

History of Present Illness

Mr. Humphrey returns three months after his last visit, nine months after his operation and five weeks after his annual wellness visit. He takes sodium bicarbonate twice a day without stomach upset, and the late-afternoon tiredness has gone. He has had no fever, flank pain, or further infection, and no leaks; he changes the appliance every four days. He has had no bone pain, cough, weight loss, change in bowel habit, or rectal bleeding. He works full time and walks 30 minutes most days. [S]

ElementDetail
AcidosisTiredness resolved on sodium bicarbonate
StomaNo leaks; skin healthy
Recurrence symptomsNone
FunctionWorking full time; walking daily

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy back to normal; weight up; no fever
GenitourinaryNegativeClear urine; no flank pain
GastrointestinalNegativeNo stomach upset on bicarbonate; no change in bowel habit or bleeding
MusculoskeletalNegativeNo bone pain
RespiratoryNegativeNo cough
PsychiatricNegativeMood good; PHQ-2 score 0

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sodium bicarbonate 650 mg oral tablet, one tablet by mouth twice daily, for metabolic acidosis after an ileal conduitOne tablet twice dailyOral route2026-04-07activeS
Ciprofloxacin 500 mg oral tablet, one tablet by mouth twice daily for 7 days, for acute pyelonephritisOne tablet twice daily for 7 daysOral route2026-03-17 to 2026-03-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-07Body height180cmS
2026-07-07Body weight78.8kgS
2026-07-07Body mass index (BMI) [Ratio]24.3kg/m2S
2026-07-07Systolic blood pressure128mm[Hg]S
2026-07-07Diastolic blood pressure76mm[Hg]S
2026-07-07Heart rate70/minS
2026-07-07Respiratory rate14/minS
2026-07-07Body temperature36.7CelS
2026-07-07Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-07Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-07-07Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-07-07Chloride [Moles/volume] in Serum or Plasma106mmol/L98-107 mmol/LNormalS
2026-07-07Carbon dioxide, total [Moles/volume] in Serum or Plasma24mmol/L22-29 mmol/LNormalS
2026-07-07Urea nitrogen [Mass/volume] in Serum or Plasma17mg/dL8-23 mg/dLNormalS
2026-07-07Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-07-07Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M74mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-07Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 2026-07-07; see the Vital Signs section. [S]

SystemFinding
GeneralWell
AbdomenSoft and non-tender; no masses; no hernia
StomaPink and moist; peristomal skin healthy
Lymph nodesNo inguinal or supraclavicular nodes
ExtremitiesNo edema

Problems

ProblemClinical statusVerificationCodeProvenance
Urothelial carcinoma of the bladder, multifocal, with carcinoma in situ, pT2a pN0 (0 of 18 nodes), margins negative, treated by radical cystoprostatectomy with an ileal conduit; no evidence of disease; under surveillance; synthetic modern detail linked to his documented bladder canceractiveconfirmed Z85.51S — Synthetic grade, stage, node count, and margins; the bladder growths, the earlier thiotepa and X-ray therapy, the low-grade malignancy, and the radical cystectomy with a small-intestine conduit are documented (D). Z85.51 is used because the tumor has been removed and no further treatment is directed at it.
Ileal conduit urostomy, right lower abdomenactiveconfirmed Z93.6S — The small-intestine conduit and the stoma to the right of the navel are documented (D); the coding and the stoma findings are synthetic.
Acquired absence of the bladder and part of the urethra after radical cystectomyactiveconfirmed Z90.6S — Documented operation (D); synthetic coding.
Acquired absence of the prostate after cystoprostatectomyactiveconfirmed Z90.79S — Documented operation (D); synthetic coding.
Personal history of pelvic radiation for bladder tumor, with earlier intravesical thiotepaactiveconfirmed Z92.3S — The thiotepa and X-ray therapy are documented (D); the coding and their relevance to the modern episode are synthetic.
Hyperchloremic metabolic acidosis from the ileal conduit, mildactiveconfirmed E87.22S — Synthetic finding at the six-month visit, a known effect of urine contact with the ileal segment.
Acute right pyelonephritis with an ileal conduit (Escherichia coli), with mild acute kidney injury, treated with oral ciprofloxacin and resolvedresolvedconfirmed N10S — Synthetic intercurrent infection at an unscheduled visit, a common complication of an ileal conduit; it does not echo a documented illness of his after the operation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryChemistry with creatinine, chloride, and bicarbonateEvery 3 to 6 months in the first year after diversion, then yearlyCompleted todayCreatinine 1.10 mg/dL, eGFR 74; chloride 106, bicarbonate 24 mmol/L on treatment
LaboratoryVitamin B12Yearly from two to three years after an ileal diversionUp to dateBaseline normal six months ago
ImagingCT of the chest, abdomen, and pelvis (with urographic phase)Every 6 to 12 months for 2 to 3 years after cystectomy, then yearlyDueAt one year after surgery, in three months; the urographic phase covers the upper tracts
ImagingUpper-tract imaging (renal ultrasound or CT urography)Every 6 months to year 3, then yearlyUp to dateRenal ultrasound three months ago without hydronephrosis; next with the CT
ExaminationStoma and peristomal skinEvery visitCompleted todayHealthy
ExaminationParastomal and incisional herniaEvery visitCompleted todayNone
Medication safetySodium bicarbonate: tolerance and sodium loadEvery visit on alkali therapyCompleted todayNo bloating; blood pressure 128/76 mm Hg; no edema
SurveyDistress and depression screen (PHQ-2)Every visitCompleted todayPHQ-2 score 0
LaboratoryRoutine urine culture of conduit urineOnly for fever, flank pain, or other signs of infectionNot indicatedBacteria are expected in conduit urine; no symptoms today
LaboratoryUrethral wash cytologyPeriodically if the urethra is retained and at high riskNot indicatedUrethral margin negative and no prostatic urethral involvement
Self-managementSurvivorship care plan, fluid intake, and activityAfter treatment; fluids and activity every visitCompleted todayWritten plan given; about 2 liters of fluid a day; walking 30 minutes most days

Goal progress:

Guideline basis: Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol 2024;212(1):3-10 (2024); NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (2026); CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026)

Follow-up: CT and urology review in three months, at one year after surgery. Primary care at the same time with chemistry. [S]